je.st
news
HSBC Reaffirms "Hold" Rating for AstraZeneca plc
2016-04-10 06:59:34| Biotech - Topix.net
's stock had its "hold" rating reissued by equities research analysts at HSBC in a research report issued to clients and investors on Thursday, Analyst Ratings.Net reports. They presently have a GBX 4,350 price target on the biopharmaceutical company's stock.
Tags: rating
hold
plc
hsbc
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||